Status:
COMPLETED
Predicting Dietary Selenium Needs to Achieve Target Blood Selenium Levels
Lead Sponsor:
USDA Grand Forks Human Nutrition Research Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Nutritional Requirements
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study, we will evaluate the effectiveness of several doses of oral selenomethionine in raising biomarkers of selenium status including plasma selenium concentrations.
Detailed Description
Results of studies with animal tumor models and human clinical trials suggest that the essential nutrient selenium can be anti-tumorigenic if consumed at levels greater than nutritional requirements. ...
Eligibility Criteria
Inclusion
- able to swallow capsules
- body mass index less than 40
Exclusion
- Pregnancy
- Chronic liver or kidney disease
- taking medication that might affect liver and/or kidney
- blood pressure 140/90 or higher
- already taking more than 50 micrograms of selenium
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
262 Patients enrolled
Trial Details
Trial ID
NCT00803699
Start Date
November 1 2005
End Date
September 1 2007
Last Update
May 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
USDA Grand Forks Human Nutrition Research Center
Grand Forks, North Dakota, United States, 58202